logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Development of dual-class antiretroviral drug resistance in a child coinfected with HIV and tuberculosis: a case report from KwaZulu-Natal, South Africa

Murphy RA, France H, Sunpath H, Gordon ML, Marconi VC, Kuritzkes DR, McIntosh K
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
The treatment of concurrent HIV and tuberculosis (TB) in children <3 years of age has not been well-studied and is complicated by potential drug-drug interactions. The recommended antiretroviral therapy (ART) in coinfected children in South Africa consists of full-strength ritonavir, lamivudine and stavudine. We report on a child initiated on this regimen, during concurrent TB treatment, who promptly developed an adverse reaction, virologic failure and dual-class antiretroviral drug resistance, compromising subsequent salvage ART.

Countries

South Africa

Subject Area

tuberculosis

Languages

English
DOI
10.1093/tropej/fmn074
Published Date
01 Feb 2009
PubMed ID
18786985
Journal
Journal of Tropical Pediatrics
Volume | Issue | Pages
Volume 55, Issue 1
Issue Date
2007-11-29
Dimensions Badge